PCRX vs EVO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 23, 2026
PCRX
EVO
Investment Advisor Scores
EVO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | EVO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.2696 | 19.9203 | PCRX |
| PEG Ratio | 11.2121 | 1.4223 | EVO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 6.2% | -16.2% | PCRX |
| Earnings Growth | -30.0% | 0.0% | EVO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 61.5/100 | 44.0/100 | PCRX |
| Profit Margin | 2.0% | -27.5% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
NeutralMixed signals - no dominant trend phase, RSI 51
EVO
MarkdownPrice below a falling SMA50 (slope -15.1%), weak momentum, RSI 40
Fundamentals Snapshot
| Metric | PCRX | EVO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.3 | 22.9 |
| Trailing P/E | 71.5 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | -0.2% |
| Gross Margin | 0.8% | 0.1% |
| Operating Margin | 0.1% | -0.6% |
| EPS | 0.35 | -0.63 |
| Dividend Yield | — | — |